Volume 64 Issue Suplemento 3 2017 - (May 2017)

• Conference Communications

  XL Reunión Anual de la Sociedad Española de Neurología Pediátrica (SENEP)

  XL Reunión Anual de la Sociedad Española de Neurología Pediátrica (SENEP)

  C Lopez, J Carlos, MJ Larena-Avellaneda, I Gonzalez Esmoris, ... R Casañas Barrios

  Rev Neurol 2017, 64(Suplemento 3), 81–391

  https://doi.org/10.33588/rn.64S03.2017204
• Innovative treatments in neuropediatrics

  Possible treatments for infantile spinal atrophy

  Posibilidades de tratamiento en la atrofia espinal infantil

  S.I. Pascual-Pascual, M. García-Romero

  Rev Neurol 2017, 64(Suplemento 3), 19–24

  https://doi.org/10.33588/rn.64S03.2017173
• How should we address epileptic encephalopathies in infants?

  How must we manage epileptic encephalopathies in infants? Conclusions

  ¿Cómo debemos abordar las encefalopatías epilépticas del lactante? Conclusiones

  V. Soto-Insuga

  Rev Neurol 2017, 64(Suplemento 3), 77–80

  https://doi.org/10.33588/rn.64S03.2017174
• Update on infectious and immunological pathology in neuropediatrics

  Importance of enteroviruses in neuropaediatrics: from polioviruses to other enteroviruses

  Importancia de los enterovirus en neuropediatría: de los poliovirus a otros enterovirus

  Grupo para el Estudio de las Infecciones por Enterovirus y Parechovirus, M. Cabrerizo

  Rev Neurol 2017, 64(Suplemento 3), 35–38

  https://doi.org/10.33588/rn.64S03.2017177
• How should we address epileptic encephalopathies in infants?

  Neuroimaging in epileptic encephalopathies in infants

  Neuroimagen en las encefalopatías epilépticas del lactante

  M.A. López-Pino, E. García-Esparza

  Rev Neurol 2017, 64(Suplemento 3), 61–64

  https://doi.org/10.33588/rn.64S03.2017165
• How should we address epileptic encephalopathies in infants?

  Infantile epileptic encephalopathies: what matters is genetics

  Encefalopatías epilépticas del lactante: lo prioritario es el estudio genético

  J.J. García-Peñas, M. Jiménez-Legido

  Rev Neurol 2017, 64(Suplemento 3), 65–69

  https://doi.org/10.33588/rn.64S03.2017166
• How should we address epileptic encephalopathies in infants?

  Epileptic encephalopathies in infancy. How do we treat them? Does the aetiology influence the response to treatment?

  Encefalopatías epilépticas del lactante. ¿Cómo las tratamos? ¿Influye la etiología en la respuesta al tratamiento?

  S. Roldán-Aparicio

  Rev Neurol 2017, 64(Suplemento 3), 71–75

  https://doi.org/10.33588/rn.64S03.2017167
• How should we address epileptic encephalopathies in infants?

  Epileptic encephalopathies

  Encefalopatías epilépticas

  J. Ramos-Lizana

  Rev Neurol 2017, 64(Suplemento 3), 45–48

  https://doi.org/10.33588/rn.64S03.2017162
• How should we address epileptic encephalopathies in infants?

  Metabolic approach in epileptic encephalopathies in infants

  Abordaje metabólico en las encefalopatías epilépticas del lactante

  L. López-Marín

  Rev Neurol 2017, 64(Suplemento 3), 49–53

  https://doi.org/10.33588/rn.64S03.2017163
• How should we address epileptic encephalopathies in infants?

  Epileptic spasms in infants. Beyond hypsarrhythmia

  Espasmos epilépticos en el lactante. Más allá de la hipsarritmia

  M. García-Fernández

  Rev Neurol 2017, 64(Suplemento 3), 55–59

  https://doi.org/10.33588/rn.64S03.2017164
• Innovative treatments in neuropediatrics

  Novel therapies in neurometabolic diseases: the importance of early intervention

  Terapias novedosas en enfermedades neurometabólicas: importancia de una intervención precoz

  L.G. Gutiérrez-Solana

  Rev Neurol 2017, 64(Suplemento 3), 25–28

  https://doi.org/10.33588/rn.64S03.2017159
• Update on infectious and immunological pathology in neuropediatrics

  Update on congenital and neonatal herpes infections: infection due to cytomegalovirus and herpes simplex

  Actualización en infecciones herpéticas congénitas y neonatales: infección por citomegalovirus y herpes simple

  F. Baquero-Artigao

  Rev Neurol 2017, 64(Suplemento 3), 29–33

  https://doi.org/10.33588/rn.64S03.2017160
• Update on infectious and immunological pathology in neuropediatrics

  Autoimmune pathology in neuropaediatrics: what aspects have really undergone a change

  Patología autoinmune en neuropediatría: en qué aspectos ha existido realmente un cambio

  V. Cantarín-Extremera

  Rev Neurol 2017, 64(Suplemento 3), 39–44

  https://doi.org/10.33588/rn.64S03.2017161
• Brain damage sustained in childhood

  Rehabilitation treatment in child and youth patients with acquired brain injury

  Tratamiento rehabilitador en el paciente infantojuvenil con daño cerebral adquirido

  M.T. Varas-Arias, S. Rodríguez-Palero

  Rev Neurol 2017, 64(Suplemento 3), 1–7

  https://doi.org/10.33588/rn.64S03.2017156
• Brain damage sustained in childhood

  Infantile acquired brain injury, a personal experience. Demands from the socio-familial point of view

  Daño cerebral sobrevenido infantil, una experiencia personal. Reclamaciones desde el punto de vista sociofamiliar

  P. Pastor-Alfonso

  Rev Neurol 2017, 64(Suplemento 3), 9–12

  https://doi.org/10.33588/rn.64S03.2017158
• Innovative treatments in neuropediatrics

  Actualización del tratamiento de las rasopatías

  Actualización del tratamiento de las rasopatías

  A. Duat-Rodríguez, Á. Hernández-Martín

  Rev Neurol 2017, 64(Suplemento 3), 13–17

  https://doi.org/10.33588/rn.64S03.2017157